Literature DB >> 30029699

In Atp7b-/- Mice Modeling Wilson's Disease Liver Repopulation With Bone Marrow-Derived Myofibroblasts or Inflammatory Cells and Not Hepatocytes Is Deleterious.

Yogeshwar Sharma1, Jinghua Liu2, Kathleen E Kristian3, Antonia Follenzi4, Sanjeev Gupta1.   

Abstract

In Wilson's disease, Atp7b mutations impair copper excretion with liver or brain damage. Healthy transplanted hepatocytes repopulate the liver, excrete copper, and reverse hepatic damage in animal models of Wilson's disease. In Fah-/- mice with tyrosinemia and α-1 antitrypsin mutant mice, liver disease is resolved by expansions of healthy hepatocytes derived from transplanted healthy bone marrow stem cells. This potential of stem cells has not been defined for Wilson's disease. In diseased Atp7b-/- mice, we reconstituted bone marrow with donor cells expressing green fluorescent protein reporter from healthy transgenic mice. Mature hepatocytes originating from donor bone marrow were identified by immunostaining for green fluorescence protein and bile canalicular marker, dipeptidylpeptidase-4. Mesenchymal and inflammatory cell markers were used for other cells from donor bone marrow cells. Gene expression, liver tests, and tissues were analyzed for outcomes in Atp7b-/- mice. After bone marrow transplantation in Atp7b-/- mice, donor-derived hepatocytes containing bile canaliculi appeared within weeks. Despite this maturity, donor-derived hepatocytes neither divided nor expanded. The liver of Atp7b-/- mice was not repopulated by donor-derived hepatocytes: Atp7b mRNA remained undetectable; liver tests, copper content, and fibrosis actually worsened. Restriction of proliferation in hepatocytes accompanied oxidative DNA damage. By contrast, donor-derived mesenchymal and inflammatory cells extensively proliferated. These contributed to fibrogenesis through greater expression of inflammatory cytokines. In Wilson's disease, donor bone marrow-derived cells underwent different fates: hepatocytes failed to proliferate; inflammatory cells proliferated to worsen disease outcomes. This will help guide stem cell therapies for conditions with proinflammatory or profibrogenic microenvironments.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30029699      PMCID: PMC6290324          DOI: 10.3727/105221618X15320123457380

Source DB:  PubMed          Journal:  Gene Expr        ISSN: 1052-2166


  41 in total

1.  Long-term metabolic correction of Wilson's disease in a murine model by gene therapy.

Authors:  Oihana Murillo; Daniel Moreno Luqui; Cristina Gazquez; Debora Martinez-Espartosa; Iñigo Navarro-Blasco; Jose Ignacio Monreal; Laura Guembe; Armando Moreno-Cermeño; Fernando J Corrales; Jesus Prieto; Ruben Hernandez-Alcoceba; Gloria Gonzalez-Aseguinolaza
Journal:  J Hepatol       Date:  2015-09-25       Impact factor: 25.083

2.  Role of bone marrow transplantation for correcting hemophilia A in mice.

Authors:  Antonia Follenzi; Sanj Raut; Simone Merlin; Rita Sarkar; Sanjeev Gupta
Journal:  Blood       Date:  2012-02-24       Impact factor: 22.113

3.  Inhibition of rat hepatocyte proliferation by transforming growth factor beta and glucagon is associated with inhibition of ERK2 and p70 S6 kinase.

Authors:  M Dixon; L Agius; S J Yeaman; C P Day
Journal:  Hepatology       Date:  1999-05       Impact factor: 17.425

4.  A humanized mouse model of liver fibrosis following expansion of transplanted hepatic stellate cells.

Authors:  Daniel Benten; Johannes Kluwe; Jan W Wirth; Nina D Thiele; Antonia Follenzi; Kuldeep K Bhargava; Christopher J Palestro; Michael Koepke; Reni Tjandra; Tassilo Volz; Marc Lutgehetmann; Sanjeev Gupta
Journal:  Lab Invest       Date:  2018-01-19       Impact factor: 5.662

5.  Demonstrating Potential of Cell Therapy for Wilson's Disease with the Long-Evans Cinnamon Rat Model.

Authors:  Fadi Luc Jaber; Yogeshwar Sharma; Sanjeev Gupta
Journal:  Methods Mol Biol       Date:  2017

6.  99mTc-mebrofenin scintigraphy for evaluating liver disease in a rat model of Wilson's disease.

Authors:  Harmeet Malhi; Kuldeep K Bhargava; Menes O Afriyie; Irene Volenberg; Michael L Schilsky; Christopher J Palestro; Sanjeev Gupta
Journal:  J Nucl Med       Date:  2002-02       Impact factor: 10.057

7.  Differentiation potential of human postnatal mesenchymal stem cells, mesoangioblasts, and multipotent adult progenitor cells reflected in their transcriptome and partially influenced by the culture conditions.

Authors:  Valerie D Roobrouck; Carlos Clavel; Sandra A Jacobs; Fernando Ulloa-Montoya; Stefania Crippa; Abhishek Sohni; Scott J Roberts; Frank P Luyten; Stefaan W Van Gool; Maurilio Sampaolesi; Michel Delforge; Aernout Luttun; Catherine M Verfaillie
Journal:  Stem Cells       Date:  2011-05       Impact factor: 6.277

8.  A significant proportion of myofibroblasts are of bone marrow origin in human liver fibrosis.

Authors:  Stuart J Forbes; Francesco P Russo; Virginia Rey; Patrizia Burra; Massimo Rugge; Nicholas A Wright; Malcolm R Alison
Journal:  Gastroenterology       Date:  2004-04       Impact factor: 22.682

9.  Kupffer Cell Transplantation in Mice for Elucidating Monocyte/Macrophage Biology and for Potential in Cell or Gene Therapy.

Authors:  Simone Merlin; Kuldeep K Bhargava; Gabriella Ranaldo; Diego Zanolini; Christopher J Palestro; Laura Santambrogio; Maria Prat; Antonia Follenzi; Sanjeev Gupta
Journal:  Am J Pathol       Date:  2016-01-07       Impact factor: 4.307

10.  Hepatocyte transplantation-induced liver inflammation is driven by cytokines-chemokines associated with neutrophils and Kupffer cells.

Authors:  Natan Krohn; Sorabh Kapoor; Yuta Enami; Antonia Follenzi; Sriram Bandi; Brigid Joseph; Sanjeev Gupta
Journal:  Gastroenterology       Date:  2009-05       Impact factor: 33.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.